A powerful protein that could help cure certain types of blindness has made its way from a tiny Connecticut laboratory to the International Space Station, WNPR reports.
The protein is a light-activated molecule called bacteriorhodopsin that is extremely light-sensitive.
Researchers believe the protein could be used to replace cells that die because of diseases like retinitis pigmentosa and age-related macular degeneration.
LambdaVision, the company that is pioneering the process, builds its organic implants by layering the protein onto a film and dipping it over and over into a series of solutions.
The process works best when those solutions are uniform, but gravity doesn't help. So LambdaVision secured a spot for their experiment on the International Space Station.
Read the full story: